{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:00:34Z","timestamp":1790283634947,"version":"4.1.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Paclitaxel-coated balloon (PCB) angioplasty is a mainstream treatment for peripheral artery disease; however, the safety of PCB remains controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We confirmed acute occlusion during PCB angioplasty in a patient with femoropopliteal artery occlusion. The occluded vessels were revascularized completely after endovascular medical therapy and bailout stenting angioplasty. Then, the patient experienced persistent post-procedure orthostatic hypotension (30 days) and received hydration and vasoactive agents with a target mean arterial blood pressure of 75\u201385 mmHg. The patient's blood pressure gradually recovered over the 30 days after the procedure, and there was no recurrence of symptomatic hypotension during the follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This rare complication is helpful to evaluate the safety of the PCB device.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.964601","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T06:44:04Z","timestamp":1665729844000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Unusual persistent hypotension and acute occlusion after peripheral paclitaxel balloon angioplasty"],"prefix":"10.3389","volume":"9","author":[{"given":"Lin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1161\/CIR.0000000000000501","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1148\/radiol.2481071159","article-title":"Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience","volume":"248","author":"Dick","year":"2008","journal-title":"Radiology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ccd.21104","article-title":"Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease","volume":"69","author":"Rocha-Singh","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"B7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11886-015-0586-8","article-title":"Drug-coated balloon and stent therapies for endovascular treatment of atherosclerotic superficial femoral artery disease","volume":"17","author":"Banerjee","year":"2015","journal-title":"Curr Cardiol Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B9","first-page":"1295","article-title":"Long lasting, grade IV, orthostatic hypotension after a single cycle combination chemotherapy with paclitaxel and cisplatin","volume":"34","author":"Vassilomanolakis","year":"1998","journal-title":"Eur J Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ahj.2006.11.020","article-title":"Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials","volume":"153","author":"De Luca","year":"2007","journal-title":"Am Heart J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jcin.2011.05.014","article-title":"Saphenous vein graft intervention","volume":"4","author":"Lee","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"B14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1526602817698634","article-title":"Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease","volume":"24","author":"Fujihara","year":"2017","journal-title":"J Endovasc Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I trial","volume":"9","author":"Jia","year":"2016","journal-title":"J Am Coll Cardiol Intv."},{"key":"B16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.xphs.2016.10.004","article-title":"Characterization of synthesized and commercial forms of magnesium stearate using differential scanning calorimetry, thermogravimetric analysis, powder x-ray diffraction, and solid-state NMR spectroscopy","volume":"106","author":"Delaney","year":"2017","journal-title":"J Pharm Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0959-8049(97)00044-0","article-title":"Paclitaxel changes sympathetic control of blood pressure","volume":"33","author":"Ekholm","year":"1997","journal-title":"Eur J Cancer."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1200\/JCO.1991.9.9.1704","article-title":"Cardiac disturbances during the administration of taxol","volume":"9","author":"Rowinsky","year":"1991","journal-title":"J Clin Oncol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.964601\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T06:44:08Z","timestamp":1665729848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.964601\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":18,"alternative-id":["10.3389\/fcvm.2022.964601"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.964601","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"article-number":"964601"}}